Pfizer Media Center - News Releases
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
Pfizer Invites Public to View and Listen to Webcasts of Pfizer Presentations at Healthcare Conferences
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - March 12, 2007 Category: Pharmaceuticals Source Type: news
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Only-Approved Cholesterol-Lowering Medication for Reducing the Risk of Hospitalization for Heart Failure
Source: Pfizer Media Center - News Releases - March 7, 2007 Category: Pharmaceuticals Source Type: news
Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care DatabaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Real-World Implications for Patients, Providers and Healthcare Systems Seeking Quality Care; Pfizer to Further Explore These Benefits in Partnership with Others
Source: Pfizer Media Center - News Releases - March 2, 2007 Category: Pharmaceuticals Source Type: news
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pivotal Data Presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI)
Source: Pfizer Media Center - News Releases - March 1, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Wins Challenge to Norvasc Patent by MylanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - February 27, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead DirectorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - February 23, 2007 Category: Pharmaceuticals Source Type: news
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor ProductEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - February 23, 2007 Category: Pharmaceuticals Source Type: news
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and EuropeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
If Approved, Maraviroc will be the First in a New Class of Medications Available for HIV Treatment
Source: Pfizer Media Center - News Releases - February 13, 2007 Category: Pharmaceuticals Source Type: news
Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in LabelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Labeling Based on Efficacy Data from a Large Phase 3 Clinical Trial Which Showed Superiority of Sutent to Standard Therapy Across Key Endpoints
Source: Pfizer Media Center - News Releases - February 8, 2007 Category: Pharmaceuticals Source Type: news
New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of Hospitalizations Due to Heart Failure in Patients with Coronary Heart DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- - -
Source: Pfizer Media Center - News Releases - February 7, 2007 Category: Pharmaceuticals Source Type: news
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes PipelineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Acquisition is a Further Step in Pfizer Strategy to Accelerate Business Development and Licensing Activity
Source: Pfizer Media Center - News Releases - February 1, 2007 Category: Pharmaceuticals Source Type: news
Court Rules In Pfizer's Favor In Norvasc Patent Case, Finds Synthon Obtained Patent By Inequitable ConductEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - January 31, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Gains Favorable Ruling From Canadian Court on Lipitor Basic Patent, Will Appeal Ruling on Calcium Salt PatentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - January 26, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Announces Priorities to Drive Improved Performance, Position Company for Future Success and Enhance Total Shareholder ReturnEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company's Plan Focuses On:
Source: Pfizer Media Center - News Releases - January 22, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Achieves Key 2006 Financial TargetsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- Full-Year 2006 Revenues Grew 2 Percent to $48.4 Billion, Key Products Substantially Attained Targets, Nine Exceeded $1 Billion in Sales
Source: Pfizer Media Center - News Releases - January 22, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Animal Health Completes Acquisition of Embrex, Inc.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - January 19, 2007 Category: Pharmaceuticals Source Type: news
Pfizer’s Sutent® is Granted Full Marketing Authorization for First-Line Use in Advanced Kidney Cancer in the European UnionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Full marketing authorization and extension of indication to first-line treatment of advanced and/or metastatic renal cell carcinoma (MRCC).
Source: Pfizer Media Center - News Releases - January 18, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Invites Public to View and Listen to Webcast of January 22 Meeting with AnalystsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - January 16, 2007 Category: Pharmaceuticals Source Type: news
Pfizer Completes Sale of Consumer Healthcare BusinessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company to Use Proceeds from Sale Combined with Strong Operating Cash Flow to Invest in Growth of Core Pharmaceutical Business
Source: Pfizer Media Center - News Releases - December 20, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Launches On-Line Site for Tracking Development Compounds Across its Largest-Ever PipelineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Site Part of Pfizer Commitment to Enhanced Transparency for Investors As Well As Scientific and Medical Communities
Source: Pfizer Media Center - News Releases - December 20, 2006 Category: Pharmaceuticals Source Type: news
Australian Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy ProductEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Lipitor Protected from Generic Competition in Australia until 2012
Source: Pfizer Media Center - News Releases - December 20, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Board of Directors Names Chief Executive Officer Jeffrey B. Kindler Chairman of the BoardEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Increases Dividend 21 Percent to 29 Cents Per Share for the First Quarter of 2007 as Part of Continuing Focus on Total Return to Shareholders
Source: Pfizer Media Center - News Releases - December 18, 2006 Category: Pharmaceuticals Source Type: news
New Data On Pfizer's Aromasin and Ellence to Be Presented at San Antonio Breast Cancer SymposiumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Begins a Phase III Trial to Study Sutent® in Patients with Advanced Breast Cancer
Source: Pfizer Media Center - News Releases - December 14, 2006 Category: Pharmaceuticals Source Type: news
Court Denies Novo Nordisk's Motion for Preliminary Injunction Against ExuberaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - December 14, 2006 Category: Pharmaceuticals Source Type: news
Canadian Federal Court Upholds Lipitor Patent, Decision Will Prevent Launch of Generic Product Until 2010Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - December 8, 2006 Category: Pharmaceuticals Source Type: news
In Interests of Patient Safety, Pfizer Stops All Torcetrapib Clinical Trials; Company Has Notified FDA and is in the Process of Notifying All Clinical Investigators and Other Regulatory AuthoritiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Decision Based on Recommendation Received Today of Independent Data Safety Monitoring Board for ILLUMINATE Trial; Pfizer Will Discontinue Development of Compound
Source: Pfizer Media Center - News Releases - December 3, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Announces Plans to Establish Expanded Access Program for Maraviroc, Investigational HIV CCR5 AntagonistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Broad Access Program for Patients with Limited Available Treatment Options
Source: Pfizer Media Center - News Releases - December 1, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Presents Robust and Diversified Product Pipeline Across 11 Therapeutic AreasEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - November 30, 2006 Category: Pharmaceuticals Source Type: news
As Initial Step in Transformation Strategy and Review of All Business Units, Pfizer to Align U.S. Sales Organization to Support Its Key Products and Customer NeedsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Says Representatives Are Critical Competitive Advantage and Core Asset in Communicating Value of Medicines
Source: Pfizer Media Center - News Releases - November 28, 2006 Category: Pharmaceuticals Source Type: news
Como Paso Inicial en la Estrategia de Transformación y Evaluación de Todas las Unidades de Negocio, Pfizer Alineará la Organización de Ventas en EE.UU. para Apoyar sus Productos Clave y las Necesidades de los ClientesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Dice que los Representantes son una Ventaja Competitiva Crítica y un Bien Clave en la Comunicación de Valores de los Medicamentos
Source: Pfizer Media Center - News Releases - November 28, 2006 Category: Pharmaceuticals Source Type: news
Organon and Pfizer Discontinue Their Collaboration on AsenapineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - November 28, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Invites Public to Listen to Webcast of November 30 Meeting With AnalystsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - November 22, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Announces Settlement With Teva on Patents Covering Cancer Medicine and AntibioticEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - November 21, 2006 Category: Pharmaceuticals Source Type: news
Intensive Lipitor Therapy Reduced Heart Attack and Stroke By One-Third In Patients With Chronic Kidney Disease, New Analysis ShowsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
* Patients with heart disease and chronic kidney disease who took intensive Lipitor therapy (80 mg) reduced their risk of heart attack and stroke by 32 percent compared with patients taking low-dose Lipitor (10 mg).
Source: Pfizer Media Center - News Releases - November 15, 2006 Category: Pharmaceuticals Source Type: news
Results of New Combined Analysis Concludes Patients at Risk for Glaucoma Will Benefit From Risk Assessment ToolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- New data confirm a five-year risk assessment tool will help ophthalmologists better predict which patients have an increased risk of developing glaucoma
Source: Pfizer Media Center - News Releases - November 15, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - November 15, 2006 Category: Pharmaceuticals Source Type: news
Arkansas and Pfizer Announce a New Partnership to Encourage the State’s Children and their Families to Embrace Healthier Eating and FitnessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Innovative Public Health Improvement Initiative Provides Community-based Education and Support Services in Three Arkansas School Districts
Source: Pfizer Media Center - News Releases - November 2, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Updates Preliminary Results of Torcetrapib/Atorvastatin Clinical Trials as Abstract for Phase 3 Study is ReleasedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 31, 2006 Category: Pharmaceuticals Source Type: news
European Patent Office Supports Validity of Lipitor PatentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Madrid, Spain Court of Appeal Confirms Pfizer's Patent Claims
Source: Pfizer Media Center - News Releases - October 27, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Declares a 24-Cent Fourth-Quarter, 2006, DividendEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 26, 2006 Category: Pharmaceuticals Source Type: news
Dennis A. Ausiello To Join Pfizer Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 26, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Assists World Health Organization in Search for New Treatments Against Diseases of the Developing WorldEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Opens its Compound Library to Help Search for New Anti-Parasitic Medicines
Source: Pfizer Media Center - News Releases - October 26, 2006 Category: Pharmaceuticals Source Type: news
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor CaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- - -
Source: Pfizer Media Center - News Releases - October 23, 2006 Category: Pharmaceuticals Source Type: news
Pfizer to Transform In Rapidly Changing Healthcare EnvironmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- Company Delivers Solid Third-Quarter 2006 Results, Led by Revenue Growth of In-Line and New Products, Confirms Previous Full-Year 2006 Guidance for Revenue and Adjusted Diluted EPS(1)
Source: Pfizer Media Center - News Releases - October 19, 2006 Category: Pharmaceuticals Source Type: news
Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor PatentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 17, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Names Senior Executive to Head Expanded Worldwide Licensing and Business DevelopmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 13, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed LtdEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Acquisition Marks Strategic Entry Into DNA-Based Vaccines
Source: Pfizer Media Center - News Releases - October 9, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Invites Public to Listen to Webcast of October 19 Conference Call with AnalystsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Pfizer Media Center - News Releases - October 5, 2006 Category: Pharmaceuticals Source Type: news
Pfizer's Anti-Smoking Pill Champix® Approved in EuropeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- More Than 1.2 Million Europeans Die of Smoking-Related Diseases Each Year; WHO Estimates the Annual Financial Burden of Smoking in Europe at $165 Billion (euro 130 Billion) by 2010
Source: Pfizer Media Center - News Releases - September 29, 2006 Category: Pharmaceuticals Source Type: news
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark BiotechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novel gene target RTP-801 offers a new approach for a potential treatment of age-related macular degeneration
Source: Pfizer Media Center - News Releases - September 26, 2006 Category: Pharmaceuticals Source Type: news
